The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121397637 12139763 7 F 20160105 20160701 20160303 20160705 EXP DE-ROCHE-1720040 ROCHE 14.49 YR M Y 68.50000 KG 20160705 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121397637 12139763 1 PS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 800 MG QOW
121397637 12139763 2 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 800 MG QOW
121397637 12139763 3 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 800 MG QOW
121397637 12139763 4 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 800 MG QOW
121397637 12139763 5 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 800 MG QOW
121397637 12139763 6 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 800 MG QOW
121397637 12139763 7 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 600 MG QOW
121397637 12139763 8 SS METHOTREXATE. METHOTREXATE 1 Oral 0 17.5 MG /wk
121397637 12139763 9 C PREDNISONE. PREDNISONE 1 Oral 0 5 MG QD
121397637 12139763 10 C PREDNISONE. PREDNISONE 1 Oral 0 7.5 MG QD
121397637 12139763 11 C ARCOXIA ETORICOXIB 1 Oral 0 90 MG BID
121397637 12139763 12 C GROWTH HORMONE SOMATROPIN 1 Subcutaneous 0 1.4 MG QD
121397637 12139763 13 C OMEPRAZOLE. OMEPRAZOLE 1 Oral 0 20 MG BID
121397637 12139763 14 C PCM (GERMANY) 2 Oral 0 500 MG TID
121397637 12139763 15 C PCM (GERMANY) 2 Oral 0 500 MG BID
121397637 12139763 16 C FOLIC ACID. FOLIC ACID 1 Oral 0 5 MG /wk

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121397637 12139763 1 Juvenile idiopathic arthritis
121397637 12139763 8 Juvenile idiopathic arthritis
121397637 12139763 9 Juvenile idiopathic arthritis
121397637 12139763 11 Juvenile idiopathic arthritis
121397637 12139763 12 Growth hormone deficiency
121397637 12139763 13 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
121397637 12139763 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
121397637 12139763 Abscess limb
121397637 12139763 General physical health deterioration
121397637 12139763 Hyperbilirubinaemia
121397637 12139763 Juvenile idiopathic arthritis
121397637 12139763 Osteoarthritis
121397637 12139763 Pain
121397637 12139763 Thrombophlebitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121397637 12139763 1 201111 0
121397637 12139763 2 20111217 0
121397637 12139763 3 20160105 0
121397637 12139763 4 20160120 0
121397637 12139763 5 20160202 0
121397637 12139763 6 20160218 0
121397637 12139763 7 20160309 0
121397637 12139763 8 20090303 0
121397637 12139763 9 20111217 0
121397637 12139763 11 20160120 0
121397637 12139763 12 20130801 0
121397637 12139763 13 20121101 0
121397637 12139763 15 20160407 0